Gold prices dropped on Thursday in Asian markets following a U.S. congress announcement reaching a deal to roll out a $2 trillion financial stimulus in a bid to bolster an economy heavily impacted by the coronavirus.
Gold Futures was unable to maintain steady gains and last traded below 0.2% to $1,629.80 by 9:24 PM ET (1:24 GMT)
In an overnight announcement, senators from U.S. congress said that the deal for the $2 trillion relief package was closing in to the voting stage as they finalize the text of the bill.
Asian equity markets had mixed sentiments on the news as investors practiced caution as the virus continues to spread.
“The big downside risk (in gold) remains the potential for those sharp sell-offs in equity markets to be repeated,” Craig Erlam, an analyst at Oanda, said in a note.
However, others expressed optimism in the precious metal.
“We still see a favorable backdrop for gold as the economic fallout from the corona crisis should strengthen safe-haven demand,” Julius Baer analyst Carsten Menke said in a CNBC interview.
Oil traded higher on Friday, further reclaiming lost ground from three-week lows in the previous session as the COVID-19 situation continued to dent the global economy as well as oil consumption. Brent crude gained 0.3%, trading at $43.08 ...
The dollar was briefly lifted on Thursday after the U.S. Federal Reserve offered no concrete clues about its next course of action, while investors hoped for an easy policy as the coronavirus resurgence stalled economic recovery. The dollar ...
The second quarter had seen Australian consumer prices dropping by a record. This could be attributed to the coronavirus crisis dragging child care cost and petroleum prices, inflicting a serious damage to years of growth toward higher inflation. Last ...
Oil prices climbed on Wednesday after U.S. crude inventories fell against analysts’ expectations, prompting a boost in the market amid the coronavirus resurgence. Brent crude futures gained 0.3%, or 14 cents, at $43.36 per barrel. U.S. ...
Britain on Wednesday signed a supply deal for up to 60 million doses of a possible COVID-19 vaccine that is being developed by pharmaceutical companies GlaxoSmithKline (GSK) and Sanofi. The financial details of the agreement were not disclosed. However, ...